[{"PropertyPlantAndEquipmentNet_0_Q2_USD":597000.0,"HeldToMaturitySecurities_0_Q2_USD":54509000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":-1006000.0,"OperatingLeaseLiability_0_Q2_USD":11686000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":131986293.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":132072996.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestPaidNet_2_Q2_USD":2094000.0,"ProceedsFromRepaymentsOfSecuredDebt_2_Q2_USD":-7200000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2989000.0,"Depreciation_2_Q2_USD":126000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":717000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":40228000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1924000.0,"AssetsCurrent_0_Q2_USD":455068000.0,"LongTermDebt_0_Q2_USD":30358000.0,"LongTermDebtCurrent_0_Q2_USD":23158000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":60779000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":34017000.0,"AdministrativeFeesExpense_2_Q2_USD":195000.0,"AdministrativeFeesExpense_1_Q2_USD":120000.0,"TreasuryStockShares_0_Q2_shares":41309.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":13255355.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":38000.0,"TreasuryStockValue_0_Q2_USD":234000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2040000.0,"Liabilities_0_Q2_USD":98270000.0,"CommonStockSharesIssued_0_Q2_shares":142873795.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10186000.0,"OtherAssetsCurrent_0_Q2_USD":2950000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":107965000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":44871000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":18541000.0,"OtherLongTermDebt_0_Q2_USD":30000000.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_0_Q2_USD":12000.0,"NotesPayableFairValueDisclosure_0_Q2_USD":717000.0,"OtherSellingGeneralAndAdministrativeExpense_2_Q2_USD":42384000.0,"OtherSellingGeneralAndAdministrativeExpense_1_Q2_USD":24729000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-76000.0,"CommonStockValue_0_Q2_USD":143000.0,"Revenues_2_Q2_USD":2338000.0,"Revenues_1_Q2_USD":1545000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":4421000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":9884000.0,"OtherResearchAndDevelopmentExpense_2_Q2_USD":93438000.0,"OtherResearchAndDevelopmentExpense_1_Q2_USD":37855000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-7217000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":16304000.0,"UnamortizedDebtIssuanceExpense_0_Q2_USD":617000.0,"RestrictedCash_0_Q2_USD":1261000.0,"DeferredRevenueNoncurrent_0_Q2_USD":533000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":147058.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_2_Q2_USD":-726000.0,"DeferredCompensationLiabilityCurrent_0_Q2_USD":8514000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":456200000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":401707000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1005000.0,"Assets_0_Q2_USD":481400000.0,"ShareBasedCompensation_1_Q2_USD":16300000.0,"LongTermInvestments_0_Q2_USD":12757000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1149722000.0,"LeaseCost_2_Q2_USD":1063000.0,"LeaseCost_1_Q2_USD":531000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-151730000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":931000.0,"CommonStockSharesOutstanding_0_Q2_shares":142832486.0,"RestrictedCashNoncurrent_0_Q2_USD":1261000.0,"AmortizationOfFinancingCosts_2_Q2_USD":463000.0,"Goodwill_0_Q2_USD":799000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-141524000.0,"ProceedsFromWarrantExercises_2_Q2_USD":166000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2035000.0,"LiabilitiesCurrent_0_Q2_USD":87551000.0,"NonoperatingIncomeExpense_2_Q2_USD":-2431000.0,"NonoperatingIncomeExpense_1_Q2_USD":-1005000.0,"InterestExpense_2_Q2_USD":3521000.0,"InterestExpense_1_Q2_USD":1623000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":402968000.0,"HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_0_Q2_USD":4000.0,"AdditionalPaidInCapital_0_Q2_USD":1532943000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":4.08,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":383130000.0,"HeldToMaturitySecuritiesFairValue_0_Q2_USD":54501000.0,"ReceivablesNetCurrent_0_Q2_USD":931000.0,"OtherIncome_1_Q2_USD":618000.0,"ShareBasedCompensation_2_Q2_USD":32922000.0,"OtherIncome_2_Q2_USD":1090000.0,"OtherLiabilitiesCurrent_0_Q2_USD":14151000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8973000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":-3863000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":6855000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1653000.0,"CommonStockSharesAuthorized_0_Q2_shares":175000000.0,"OperatingIncomeLoss_2_Q2_USD":-166694000.0,"OperatingIncomeLoss_1_Q2_USD":-77492000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":3271000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":717000.0,"InvestmentIncomeAmortizationOfPremium_2_Q2_USD":282000.0,"OperatingLeaseCost_2_Q2_USD":1063000.0,"OperatingLeaseCost_1_Q2_USD":531000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":481400000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AmortizationOfLeaseIncentives_2_Q2_USD":106000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1500000.0,"OperatingExpenses_2_Q2_USD":169032000.0,"OperatingExpenses_1_Q2_USD":79036000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":949000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.28,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.59,"ProfitLoss_2_Q2_USD":-169125000.0,"ProfitLoss_1_Q2_USD":-78497000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":242000.0,"ShortTermInvestments_0_Q2_USD":41752000.0,"Ticker":"TGTX","CIK":"1001316","name":"TG THERAPEUTICS, INC.","OfficialName":"TG Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1036853809.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]